phenoxybenzamine has been researched along with Heart Septal Defects, Ventricular in 6 studies
Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
Heart Septal Defects, Ventricular: Developmental abnormalities in any portion of the VENTRICULAR SEPTUM resulting in abnormal communications between the two lower chambers of the heart. Classification of ventricular septal defects is based on location of the communication, such as perimembranous, inlet, outlet (infundibular), central muscular, marginal muscular, or apical muscular defect.
| Excerpt | Relevance | Reference |
|---|---|---|
| "From 1971 to 1977, a total of 43 cases with ventricular septal defect associated with pulmonary hypertension (VSD + PH), ranging from 3 months to 6 years of age, underwent VSD closure using cardiopulmonary bypass with a prophylactic dose of phenoxybenzamine (POB) 1 mg/Kg." | 7.66 | The effect of phenoxybenzamine on the pulmonary vascular bed in surgically corrected ventricular septal defect associated with pulmonary hypertension. ( Asada, S; Horikoshi, K; Iwai, S; Kimura, K; Ogawa, K; Toriyama, A; Yamaguchi, M; Yamamoto, T, 1979) |
| "From 1971 to 1977, a total of 43 cases with ventricular septal defect associated with pulmonary hypertension (VSD + PH), ranging from 3 months to 6 years of age, underwent VSD closure using cardiopulmonary bypass with a prophylactic dose of phenoxybenzamine (POB) 1 mg/Kg." | 3.66 | The effect of phenoxybenzamine on the pulmonary vascular bed in surgically corrected ventricular septal defect associated with pulmonary hypertension. ( Asada, S; Horikoshi, K; Iwai, S; Kimura, K; Ogawa, K; Toriyama, A; Yamaguchi, M; Yamamoto, T, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ogawa, K | 2 |
| Yamamoto, T | 2 |
| Yamamoto, H | 1 |
| Asada, S | 2 |
| Horikoshi, K | 2 |
| Yamaguchi, M | 2 |
| Toriyama, A | 2 |
| Kaneda, H | 1 |
| Murata, H | 1 |
| Iwai, S | 1 |
| Kimura, K | 1 |
| Kidani, M | 1 |
| Noto, T | 1 |
| Synhorst, DP | 1 |
| Lauer, RM | 1 |
| Doty, DB | 1 |
| Brody, MJ | 1 |
| Ota, K | 1 |
| Taguchi, K | 1 |
| Matsuura, Y | 1 |
| Nakai, H | 1 |
| Shimamoto, M | 1 |
| Fujitani, H | 1 |
6 other studies available for phenoxybenzamine and Heart Septal Defects, Ventricular
| Article | Year |
|---|---|
[Effects of phenoxybenzamine (POB) in surgical correction of congenital heart disease with pulmonary hypertension (author's transl)].
Topics: Child; Child, Preschool; Heart Septal Defects, Ventricular; Humans; Hypertension, Pulmonary; Infant; | 1979 |
The effect of phenoxybenzamine on the pulmonary vascular bed in surgically corrected ventricular septal defect associated with pulmonary hypertension.
Topics: Blood Pressure; Child; Child, Preschool; Heart Septal Defects, Ventricular; Humans; Hypertension, Pu | 1979 |
[Use of phenoxybenzamine following surgery of ventricular septal defects associated with pulmonary hypertension].
Topics: Child; Child, Preschool; Female; Heart Septal Defects, Ventricular; Humans; Hypertension, Pulmonary; | 1976 |
Hemodynamic effects of vasodilator agents in dogs with experimental ventricular septal defects.
Topics: Animals; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Heart Septal Defects, Ventricular; | 1976 |
[Use of phenoxybenzamine (dibenzyline) in the field of heart surgery--pharmacological characteristics and action].
Topics: Body Temperature; Cardiac Surgical Procedures; Child; Ductus Arteriosus, Patent; Female; Heart Septa | 1973 |
Studies on the effects of dibenzyline on pulmonary hypertension--a preliminary report.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Heart Septal Defects, Ventricular; Humans; Hyper | 1968 |